Nicardipine Lp Laboratoire X.O (Nicardipine Hydrochloride)

Nicardipine Hydrochloride, the active ingredient in Nicardipine Lp Laboratoire X.O, is a calcium channel blocker presented as an oral tablet for oral use. It treats hypertension and chronic stable angina in adult patients. GNH USA supplies Nicardipine Lp Laboratoire X.O as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicardipine Hydrochloride acts on the cardiovascular system to manage elevated blood pressure and angina symptoms. - Hypertension: lowers systemic arterial pressure and reduces cardiovascular risk. - Chronic stable angina: decreases frequency of chest pain episodes by improving myocardial oxygen supply. - Hypertensive emergencies: provides controlled reduction of blood pressure when rapid control is needed.

Adverse reactions may occur with nicardipine therapy.

Common Side Effects: - Headache: mild to moderate pain often occurring early in treatment. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of ankles or lower legs. - Dizziness: sensation of light‑headedness, especially upon standing.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Myocardial infarction: rare occurrence of heart attack. - Allergic reaction: rash, itching, or anaphylaxis in susceptible individuals.

Before initiating nicardipine, clinicians should consider several safety measures. - Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Cardiac assessment: evaluate for underlying heart failure or recent myocardial infarction. - Concomitant antihypertensives: adjust doses to prevent additive hypotensive effects. - Hepatic impairment: use with caution in patients with liver dysfunction. - Discontinuation: avoid abrupt cessation to prevent rebound hypertension. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nicardipine may interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase nicardipine plasma levels. - Other calcium channel blockers: additive vasodilatory effect leading to hypotension. - Nitrates: risk of severe hypotension when combined.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance blood‑pressure‑lowering effect. - ACE inhibitors or ARBs: monitor for excessive blood pressure reduction.